<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ZGEN News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=zgen</link><description>Latest Financial News for ZymoGenetics, Inc.</description><language>en-us</language><lastBuildDate>Tue, 22 Dec 2009 16:42:41 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>ZymoGenetics Amends Recothrom Deal (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091222/28582.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1123328307</guid><pubDate>Tue, 22 Dec 2009 16:42:41 Etc/GMT</pubDate></item><item><title>ZymoGenetics, Bayer scale back partnership (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=129vmlb3m/*http%3A//seattle.bizjournals.com/seattle/stories/2009/12/21/daily6.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/535898122</guid><pubDate>Mon, 21 Dec 2009 23:05:20 Etc/GMT</pubDate></item><item><title>Bayer returns Recothrom rights to ZymoGenetics (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_zymogenetics_recothrom_marketing.html?.v=2</link><description>ZymoGenetics Inc. said Monday it regained most of the marketing rights for its only marketed product, Recothrom, from partner Bayer Schering Pharma.</description><guid isPermaLink="false">yahoo_finance/2389476562</guid><pubDate>Mon, 21 Dec 2009 22:26:44 Etc/GMT</pubDate></item><item><title>UPDATE - ZymoGenetics regains most Recothrom rights from Bayer (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh59921_2009-12-21_22-17-05_sge5bk0i9_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/2412152093</guid><pubDate>Mon, 21 Dec 2009 22:17:05 Etc/GMT</pubDate></item><item><title>ZYMOGENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091221/zgen8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4270655265</guid><pubDate>Mon, 21 Dec 2009 21:42:48 Etc/GMT</pubDate></item><item><title>ZymoGenetics and Bayer Restructure RECOTHROM® Agreements (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091221/20091221005924.html?.v=1</link><description>SEATTLE----ZymoGenetics, Inc. today announced a restructuring of the U.S. co-promotion and ex-U.S. license and collaboration agreements with Bayer Schering Pharma AG and Bayer HealthCare relating to RECOTHROM® Thrombin, topical .</description><guid isPermaLink="false">yahoo_finance/3155475199</guid><pubDate>Mon, 21 Dec 2009 21:30:00 Etc/GMT</pubDate></item><item><title>Synthetic platelets quickly stem bleeding - study (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh05648_2009-12-16_21-29-55_n1649886_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/922022236</guid><pubDate>Wed, 16 Dec 2009 21:29:55 Etc/GMT</pubDate></item><item><title>ZYMOGENETICS INC Files SEC form 8-K, Other Events (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/zgen8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1502211334</guid><pubDate>Tue, 15 Dec 2009 21:04:51 Etc/GMT</pubDate></item><item><title>ZymoGenetics shares fall on regulatory delay (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_zymogenetics_mover.html?.v=1</link><description>Shares of ZymoGenetics Inc. dipped Tuesday after the company said additional studies are likely needed to gain European regulatory approval of its only marketed product, Recothrom.</description><guid isPermaLink="false">yahoo_finance/4279443195</guid><pubDate>Tue, 15 Dec 2009 18:47:10 Etc/GMT</pubDate></item><item><title>ZymoGenetics marketing partner pulls back in Europe (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=1291tqh6k/*http%3A//seattle.bizjournals.com/seattle/stories/2009/12/14/daily1.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/1197977463</guid><pubDate>Mon, 14 Dec 2009 18:05:26 Etc/GMT</pubDate></item><item><title>ZYMOGENETICS INC Files SEC form 8-K, Other Events (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091214/zgen8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2166251885</guid><pubDate>Mon, 14 Dec 2009 11:01:47 Etc/GMT</pubDate></item><item><title>ZymoGenetics claims court win versus King (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12anmn8dv/*http%3A//seattle.bizjournals.com/seattle/stories/2009/12/07/daily40.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/619327674</guid><pubDate>Thu, 10 Dec 2009 23:05:19 Etc/GMT</pubDate></item><item><title>UPDATE - Zymogenetics says court denies King Pharma motion (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh33871_2009-12-10_20-55-02_bng410418_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/14372254</guid><pubDate>Thu, 10 Dec 2009 20:55:02 Etc/GMT</pubDate></item><item><title>ZYMOGENETICS INC Files SEC form 8-K, Other Events (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091210/zgen8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3009931753</guid><pubDate>Thu, 10 Dec 2009 19:58:52 Etc/GMT</pubDate></item><item><title>ZGEN Inks Licensing Deal (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091208/28033.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3236873254</guid><pubDate>Tue, 8 Dec 2009 13:02:22 Etc/GMT</pubDate></item><item><title>ZYMOGENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091208/zgen8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1311197244</guid><pubDate>Tue, 8 Dec 2009 11:03:19 Etc/GMT</pubDate></item><item><title>Novo Nordisk Licenses IL-21 mAb and Patent Rights to IL-21 Antibodies from ZymoGenetics (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091208/20091207005227.html?.v=1</link><description>SEATTLE &amp; COPENHAGEN----Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.</description><guid isPermaLink="false">yahoo_finance/1023693174</guid><pubDate>Tue, 8 Dec 2009 07:00:00 Etc/GMT</pubDate></item><item><title>UPDATE - ZymoGenetics cuts jobs, stops immunology research (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh45412_2009-12-03_23-05-34_bng50625_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/944997857</guid><pubDate>Thu, 3 Dec 2009 23:05:34 Etc/GMT</pubDate></item><item><title>ZYMOGENETICS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091203/zgen8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3925809573</guid><pubDate>Thu, 3 Dec 2009 22:02:23 Etc/GMT</pubDate></item><item><title>Somaxon, Kimber Resources: Midday Volume Plays (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=136mi2ifr/*http%3A//www.thestreet.com/_yahoo/story/10634715/1/somaxon-kimber-resources-midday-volume-plays.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/3356866640</guid><pubDate>Mon, 30 Nov 2009 18:17:58 Etc/GMT</pubDate></item></channel></rss><!-- c15.finance.sp2.yahoo.com compressed/chunked Sun Dec 27 07:20:38 PST 2009 -->
